ETR:DRW3

Drägerwerk AG & Co. KGaA - DRW3 Price Target & Analyst Ratings

€40.95

+0.40 (+0.99%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: €40.30
▼
€40.95
50-Day Range: €39.65
▼
€43.90
52-Week Range: €38.20
▼
€53.05

Volume: 4,105 shs
Average Volume: 33,804 shs
Market Capitalization: $352.17 million

P/E Ratio: N/A
Dividend Yield: 0.46%
Price Target: €40.05

Drägerwerk AG & Co. KGaA Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

€40.05

High Prediction	€44.10
Average Prediction	€40.05
Low Prediction	€36.00

Type	Current 3/26/22 to 3/26/23	1 Month Ago 2/24/22 to 2/24/23	3 Months Ago 12/26/21 to 12/26/22	1 Year Ago 3/26/21 to 3/26/22
Consensus Rating	N/A	N/A	N/A	Moderate Buy
Strong Buy	N/A	N/A	N/A	0 Strong Buy rating(s)
Buy	N/A	N/A	N/A	2 Buy rating(s)
Hold	N/A	N/A	N/A	2 Hold rating(s)
Sell	N/A	N/A	N/A	0 Sell rating(s)
Consensus Price Target	€40.05	€39.12	€47.43	€72.42

Get Drägerwerk AG & Co. KGaA Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for DRW3 and its competitors with MarketBeat's FREE daily newsletter.

DRW3 Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DRW3 Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Drägerwerk AG & Co. KGaA Stock vs. The Competition

Type	Drägerwerk AG & Co. KGaA	Medical Companies
Consensus Rating Score	0.00	2.64
Consensus Rating	N/A	Buy
News Sentiment Rating	Neutral News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/16/2023	Warburg Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christian Ehmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		€44.10	+4.13%
1/17/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Henrik Paganetty Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		€36.00	-11.33%
1/11/2022	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Oliver, Reinberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		€55.00	+7.32%
11/25/2021	Nord/LB Subscribe to MarketBeat All Access for the recommendation accuracy rating	Holger, Fechner Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		€72.00	+21.21%
7/16/2021	Hauck and Aufhaeuser Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aliaksandr Halitsa Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		€96.50	+29.44%
4/20/2021	DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy

4/16/2021	Independent Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target	Neutral	€78.00	+1.89%

(Data available from 3/26/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

DRW3 Price Target - Frequently Asked Questions

Does Drägerwerk AG & Co. KGaA's stock price have much downside?: According to analysts, Drägerwerk AG & Co. KGaA's stock has a predicted downside of -3.44% based on their 12-month price targets.
What analysts cover Drägerwerk AG & Co. KGaA?: Drägerwerk AG & Co. KGaA has been rated by Jefferies Financial Group, and Warburg Research in the past 90 days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

This page (ETR:DRW3) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial